Ghent University Hospital
Ghent, BelgiumPurpose
to help generate data on safety, reactogenicity and impact of using a monovalent type-2 IPV formulation to facilitate the polio eradication program and its endgame.
Grantee
Division
Global Development
Date
JULY 2013
Region served
GLOBAL
Committed amount
$557,071
Grant topic
Polio
Duration (months)
17
Grantee location
Ghent, Belgium
Related work
More about our financials
Our work
Learn about where we work around the globe and the programs we’ve created to address urgent issues in global health, global development, and education.
How we work
We are focused on results. Those that can be measured. And those measured in ways beyond numbers.